Friday, May 4, 2012

Foods That Provide Hidden Vit D Treasure

Would it surprise you to know that meat, fish, and eggs not only provide vitamin D, but a major metabolite of vitamin D3 that is absorbed five times as well as supplemental D3? 

Researchers in the June issue of American Journal of Clinical Nutrition explored the relative potency of the metabolite, 25-hydroxyvitamin D3, to vitamin D3 so that food-composition tables can better reflect the true vitamin D nutritive value of certain foods. 

The study was performed in healthy, free-living adults to investigate whether the intake of 25-hydroxyvitamin D3 is 5 times more potent in raising serum 25-hydroxyvitamin D [25(OH)D] during winter compared with an equivalent amount of vitamin D3. A randomized, placebo-controlled, double-blind intervention study was conducted in adults aged 50 years who consumed a placebo, vitamin D3, or equivalent 25-hydroxyvitamin D3 daily throughout 10 weeks of winter. Serum 25(OH)D was measured.

They found that each microgram of orally consumed 25-hydroxyvitamin D3 (the metabolite) was about 5 times more effective in raising serum 25(OH)D in older adults in winter than an equivalent amount of vitamin D3. 

30%, 12–14%, and 9% of the median daily intake of vitamin D in 18–64-y-olds comes from meat and meat products, fish and fish products, and egg and egg-dish food groupings, respectively in Ireland. Likewise, these 3 food groupings collectively make a significant contribution (55.5%) to the MDI of vitamin D in adults in the United Kingdom. In the US, adolescent girls in the National Heart, Lung and Blood Institute Growth and Health Study, the meat and bean food group contributed 4% and 26% to the MDI of vitamin D in white and African American girls, respectively.

Osteoporosis Update

Alcohol
Moderate alcohol consumption has been shown to be positively associated with increased bone mineral density (BMD). However, other lifestyle choices have also been shown to have an effect on bone health. An American Journal of Clinical Nutrition study examined the association between alcohol intake and Bone Mineral Density in 3218 women around menopause and to determine whether any association is independent of other lifestyle choices. Women who consumed one drink per day of alcohol had a significantly greater femoral neck and lumbar spine Bone Mineral Density than did those who never consumed alcohol.

Healing Bone Injuries
A human-made package filled with nature's bone-building ingredients heals serious bone injuries faster than products currently available. Tested on sheep, the surgical elastic "implant device," essentially a wrapping that mimics bone's own sock-like sheath called periosteum, delivered stem cells, growth factors and other natural components of the periosteum to heal a defect that would not heal on its own if left untreated, as reported in journal PLoS One.

Scientists filled the pockets of one set of the devices with membranes made of collagen, which is a natural component of the periosteum; a second set was filled with collagen membranes seeded with cells that reside in the periosteum , and a third set with strips of periosteum. Both the collagen seeded sheets and the periosteum strips showed the most promising results.

Beyond bone, the device is flexible enough to be used in a broad array of applications including growing cartilage for orthopedics, to fuse vertebrae, as a delivery system for stem cells, antibiotics, transcription factors and more.

Diet Patterns
According to a study in British Journal of Nutrition, studies of individual nutrients or foods have revealed much about dietary influences on bone, but not in young adults. Researchers examined the relationship between dietary patterns, and bone mineral status, the collective term for bone mineral content (BMC) and bone mineral density (BMD) in young adults (20–25 years). Women in the top compared to the bottom fifth of the ‘Nuts and Meat’ pattern had greater femoral neck BMD and BMC. Men in the top compared to the bottom fifth of the ‘Refined Carbohydrate’ pattern had lower femoral BMC. In conclusion, adherence to a ‘Nuts and Meat’ dietary pattern may be associated with greater BMS in young women and a ‘Refined’ dietary pattern may be detrimental for bone health in young men.

Supplements 
Osteoporosis International published a recent study stating that "lifetime supplementation with vitamin K, vitamin D3, and calcium is likely to reduce bone fractures and increase survival in postmenopausal women. It would be a cost-effective intervention at commonly used thresholds, but further research on the effect of vitamin K on fractures is warranted. Compared to no supplementation, vitamin D(3) (800 IU/day) with calcium (1,200 mg/day), and vitamin K(2) (45 mg/day) with vitamin D(3) and calcium (at the same doses) were examined.

Adding vitamin K(2) to vitamin D(3) with calcium reduced the lifetime probability of at least one fracture by 25%, increased discounted survival by 0.7 quality-adjusted life-years and discounted costs by $8,956 per person. Lifetime supplementation with vitamin K, vitamin D(3), and calcium is likely to reduce fractures and increase survival in postmenopausal women. Given high uncertainty around the cost-effectiveness estimates, further research on the efficacy of vitamin K on fractures is warranted. 

Bonnie: we have seen more and more positive data on vitamin K for bone fracture prevention. While it is much easier to attain from diet (especially with ideal vegetable consumption) than vitamin D, we are getting closer to including it as a required supplemental nutrient, but are not there just yet. 

Safety (or Lack Thereof) of Current Osteoporosis Drug Therapy
This was taken verbatim from the Agency for Healthcare Research and Quality latest report on the challenges of treating osteoporosis.

What are the short- and long-term harms (adverse effects) of the above therapies?     
High Participants who took raloxifene showed higher odds for pulmonary embolism than did participants who took a placebo. Raloxifene participants also had greater odds of thromboembolic events.
High Estrogen and estrogen-progestin combination participants had higher odds of cerebrovascular accident (CVA) and thromboembolic events than did placebo participants.
High A pooled analysis of ten trials found an increased risk with raloxifene for myalgias, cramps, and limb pain.
High We categorized conditions such as acid reflux, esophageal irritation, nausea, vomiting, and heartburn as “mild upper GI events.” Our pooled analyses showed alendronate had a slightly increased risk of mild upper GI events. Alendronate participants also had higher odds of mild upper GI events in head-to-head trials vs. menopausal hormone therapy. Pooled analysis also showed alendronate users to be at an increased risk for mild GI events compared to denosumab. Denosumab was also associated with an increase in mild GI events.
Low A new systematic review of 15 placebo-controlled trials of calcium (administered for bone health in all trials but one) identified a statistically significant increase in the risk of myocardial infarction; however serious concerns have been expressed about possible bias.
Moderate Teriparatide-treated participants showed a significant increase in hypercalcemia.
Insufficient The literature is equivocal on the potential association between bisphosphonates and the risk of atrial fibrillation.
High One trial, one post hoc analysis of three trials, two large observational studies, and a review of 2,408 cases of osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis prevention or treatment found that the incidence of osteonecrosis of the jaw in this group was small, ranging from less than one to 28 cases per 100,000 person-years of treatment.
High Our pooled analysis of eight trials found an increased risk with raloxifene of hot flashes.

Limited data from clinical trials and observational studies support a possible association between bisphosphonate use and atypical subtrochanteric fractures of the femur. Data are not consistent, nevertheless these data were sufficient for FDA to issue a Warning regarding this possible adverse event.
Moderate A pooled analysis of three trials of teriparatide found an increased risk of headaches.
High A pooled analysis of four trials of denosumab found an increased risk of rash but no increase in the risk for injection-site reactions.
Moderate A small number of clinical trials have reported an increased risk of hypocalcemia in patients treated with alendronate and zoledronic acid.
Insufficient Four observational studies that assessed whether the use of an oral bisphosphonate is associated with an increased risk of esophageal cancer had mixed findings.
High A pooled analysis of four trials of denosumab found an increased risk for infection.

Steve: this also is a direct quote from the report: "Dietary and supplemental calcium and vitamin D, as well as weight bearing exercise, play important roles in preserving bone mass. Lifelong calcium intake is required for the acquisition of peak bone mass and for the subsequent maintenance of bone health. When serum calcium levels are inadequate, bone tissue is resorbed from the skeleton to maintain serum calcium at a constant level. Adequate vitamin D levels play a key role in calcium absorption, bone health, muscle performance, balance, and fall prevention."

Friday, April 27, 2012

Vitamin D Update

Allergy
According to an editorial in Current Opinion in Allergy and Clinical Immunology, allergists must consider the possibility that abnormal vitamin D blood levels – or even the local tissue concentration of vitamin D – could be a critical influencing factor in chronic rhinitis and asthma onset.

Alzheimer's
In women with the average age of 80, the highest average intakes of vitamin D were associated with a 77% decrease in the risk of Alzheimer’s, according to a study in the The Journal of Gerontology: Medical Science.

Researchers have identified the key genes and celullar signalling networks regulated by vitamin D3 that may help the body clear the brain of amyloid beta, the main component of plaques associated with Alzheimer's disease. Published in the Journal of Alzheimer's Disease, the early findings show this is done by stimulating the immune system.

Back Surgery
Before considering spine-related surgery, you may want to check your vitamin D level first. Spine-related disability is higher in patients with low levels of vitamin D. A study presented at the North American Spine Society found that 65% of patients undergoing spinal fusion had vitamin D inadequacy ( below 32), which can delay recovery.

Bone Fractures
New research presented at the 2012 Annual Meeting of the American Academy of Orthopedic Surgeons found that 77 percent of orthopedic trauma patients had deficient or insufficient levels of vitamin D. Participants with vitamin D levels below 20 were categorized as "deficient," those with levels between 20 and 32 "insufficient," and levels between 40 and 70 considered "healthy".

Another study presented at the meeting stated that 44% of postmenopausal women treated for a distal radius fracture (DRF) were either vitamin D deficient or insufficient.

Cholesterol
Researchers in British Journal of Nutrition investigated evidence indicating that vitamin D deficiency contributes to abnormal lipid markers in women. Vitamin D3 supplementation in healthy premenopausal overweight and obese women were randomly allocated to receive vitamin D or placebo for 12 weeks. In addition to the significant decrease of body fat mass, the vitamin D3 group showed significantly improved HDL-cholesterol, apoA-I concentrations and LDL-cholesterol:apoB-100 ratio.

Cancer
Researchers investigated the association between serum levels of 25-hydroxyvitamin D and risk of death in Norwegian cancer patients. The study population was 658 patients with cancers of the breast (n = 251), colon (n = 52), lung (n = 210), and lymphoma (n = 145). 343 (86%) died from cancer. Patients with 25-OHD levels below 46 at diagnosis experienced shorter survival. In the Cancer, Causes, and Control study, compared to patients with the lowest of serum 25-OHD, the risk of cancer death among patients in the highest quartile was significantly reduced.

Authors of an American Journal of Epidemiology study measured plasma 25-hydroxyvitamin D in healthy volunteer who underwent total colonoscopy, and evaluated its influence on colorectal adenoma. Compared with the lowest levels of plasma 25-hydroxyvitamin D, only the highest was related to a significantly decreased odds ratio of colorectal adenoma.

Vitamin D supplements are necessary to avoid melanoma cases in temperate (colder) climates, according to a study in Cancer Causes Control. Out of 960 melanoma cases, most vitamin D levels were sub-optimal, especially in sun-sensitive individuals. Even in those with sun exposure, levels were better, but most were not considered optimal. Without supplementation, none of the cases had vitamin D levels that were considered optimal.

A Breast Cancer Research study including 1,295 incident postmenopausal breast cancer patients aged 50–74 years, found that lower serum 25(OH)D concentrations were associated with poorer overall survival and distant disease-free survival in postmenopausal breast cancer patients.

Diabetes
A higher-than-expected co-occurrence of low vitamin D levels and hyperglycemia (HbA1c more than 6.5%) are important public health concerns for older populations living in northern latitudes because both are common, and both have substantial adverse health consequences. According to the Journal of American Geriatric Society study, ensuring adequate vitamin D levels may help reverse the increasing trend in the development of diabetes mellitus and related complications in older people.

Fertility
There is evidence that vitamin D modulates reproductive processes in women and men. A European Journal of Endocrinology study found that the vitamin D receptor (VDR) and vitamin D metabolizing enzymes are found in reproductive tissues of women and men.

Researchers found that vitamin D is involved in female reproduction including in-vitro fertilization (IVF) outcome and polycystic ovary syndrome (PCOS). In PCOS women, low 25(OH)D levels are associated with obesity, metabolic and endocrine disturbances and vitamin D supplementation might improve menstrual frequency and metabolic disturbances in those women. Moreover, vitamin D might influence steroidogenesis of sex hormones (estradiol and progesterone) in healthy women.

In men, vitamin D is positively associated with semen quality and androgen status. Moreover, vitamin D treatment might increase testosterone levels.

Heart Failure
Researchers in European Journal of Heart Failure discovered that vitamin D deficiency is highly prevalent in Heart Failure patients and is a significant predictor of reduced survival. They found that vitamin D supplementation was associated with improved outcome.

Inflammation
Researchers have discovered specific molecular and signaling events by which vitamin D inhibits inflammation. In Journal of Immunology, they showed that low levels of Vitamin D, comparable to levels found in millions of people, failed to inhibit the inflammatory cascade, while levels considered adequate did inhibit inflammatory signaling. This study is the first to outline a clear chain of cellular events, from the binding of DNA, through a specific signaling pathway, to the reduction of proteins known to trigger inflammation.

Inflammatory Bowel Disease
In children and adolescents with inflammatory bowel disease (IBD) and insufficient serum vitamin D levels, taking 2,000 IU of vitamin D3 every day for six weeks, or a 50,000-IU dose of vitamin D2 every week, were both more effective at raising serum 25OHD concentration than 2,000 IU/day of vitamin D2. Vitamin D insufficiency is common in children with IBD said in a report in the Journal of Clinical Endocrinology and Metabolism.

Leprosy
A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses. In one of the first laboratory studies of its kind, the leprosy pathogen Mycobacterium leprae was able to reduce and evade immune activity that is dependent on vitamin D. Researchers believe that a combination of vitamin D supplementation with a genetically targeted therapy may provide an optimal treatment approach to leprosy.

Menstrual Cramps
Women with a history of severe menstrual cramps reported significantly less pain when they took an ultra-high dose of vitamin D (300,000IU) five days before their next expected period, an Archives of Internal Medicine report explained. While no side effects were seen, researchers point out that the vitamin D dose used in the study, even when averaged over two months, was still higher than the "tolerable upper limit" and only should be considered under the supervision of a physician.

Metabolic Syndrome
Researchers in the Journal of Clinical Endocrinology and Metabolism found that those with lower vitamin D levels were more likely to be obese and have higher degrees of insulin resistance, when the hormone becomes less effective at lowering blood sugar. Hence, the study suggests that low vitamin D levels may play a role in the development of Type 2 diabetes as well.

Multiple Sclerosis
According to a study in Archives of Neurology, low serum vitamin D levels contribute to recurrent inflammatory spinal cord disease. Vitamin D is believed to play a role in preventing monophasic immune-mediated central nervous system attacks from developing into recurrent disease, but studies are scant. Researchers found that vitamin D levels are significantly lower in patients who developed recurrent spinal cord disease. This study now provides a basis for a trial of measuring 25-hydroxyvitamin D levels in these patient populations and assessing the influence of vitamin D supplementation on the frequency of relapses in those with recurrent inflammatory spinal cord disease.

Non-Hodgkin's Lymphoma
According to a study in Cancer Causes and Control, Non-Hodgkins is tied to vitamin D deficiency. Studies of risk of non-Hodgkin’s lymphoma have found both direct and inverse correlations with respect to solar ultraviolet (UV) doses. Reduced risk is generally found in midlatitudes, while increased risk is generally found at higher latitudes. It is suggested that reduced risk arises from vitamin D production from UVB irradiance, while increased risk arises from immunosuppression associated with UVA irradiance. The ratio of UVA to UVB increases with increasing latitude..

Pain
The aim of a British Journal of Nutrition study was to investigate associations between serum 25-hydroxy vitamin D and self-reported current symptoms of pain in 2070 adults aged 65 years and older. Results show that the symptoms of moderate/extreme pain were associated with poor vitamin D status.

Pregnancy
Results of a large study in Pediatrics suggest that maternal vitamin D status during pregnancy has an effect on the neurocognitive development of offspring. Pregnant women with insufficient serum 25-hydroxyvitamin D levels (below 46) had about a 2-fold higher risk of having a child with clinically significant language difficulties compared with pregnant women whose vitamin D levels were greater than 70.

Stress Fractures
A study of 6712 girls aged 9 to 15 years in Archives of Pediatric Adolescent Medicine to estimate the association between vitamin D intake and stress fracture risk among girls participating in at least 1 h/d of high-impact activity, among whom 90.0% of the stress fractures occurred, found that higher vitamin D intake predicted significantly lower risk of stress fracture.

Sun Exposure
Light-skinned people who avoid the sun are twice as likely to suffer from vitamin D deficiency as those who do not, according to a study of nearly 6,000 people in Cancer, Causes, and Control. The study adds to a growing debate about how to balance the dangers of sun exposure with the need for appropriate levels of vitamin D.

According to a study in Environmental Health Perspectives, most American children may not be going outside enough to meet their minimal (600 IU/day) or optimal (more than 1,200 IU/day) vitamin D requirements.

Where You Live Matters
When it comes to risks for vitamin D deficiency, and the medical care and costs associated with that deficiency, where you live appears to play an important role, according to the Journal of Rural Health. Of 9396 veterans treated from 2003 to 2009, the highest levels were observed for urban residents (29.5 ng/mL), followed by rural residents (28.0 ng/mL), and the lowest for large metro residents (27.5 ng/mL).

Tuesday, April 24, 2012

Med Alert

16 Drugs on the FDA Watch List
 http://www.medscape.com/viewarticle/762205

Acne Medication

Use of isotretinoin (Roaccutane, formerly known as Accutane) to treat severe acne was linked to a two-fold risk of developing eye problems, such as pink eye, styes and dryness. Isotretinoin is known to have serious side effects, such as bone growth delays in teenagers and miscarriages and birth defects when taken by pregnant women.

The new Archives of Dermatology study found that of nearly 15,000 Israeli adolescents and young adults, 14% of those taking isotretinoin were treated for eye conditions within a year of starting the drug, compared to 7% of an acne-free comparison group.



Blood Pressure Medication
Aliskiren-containing medications are
renin inhibitors used to treat high blood pressure (hypertension). They go by the names:

Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide)
Tekturna (aliskiren hemifumarate)
Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide)
Tekamlo (aliskiren hemifumarate and amlodipine besylate)
Valturna (aliskiren hemifumarate and valsartan).


FDA notified healthcare professionals of possible risks when using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with diabetes or kidney (renal) impairment. These drug combinations should not be used (are contraindicated) in patients with diabetes. In addition, avoid use of aliskiren with ARBs or ACEIs in patients with moderate to severe renal impairment.

Bone Loss Medication 
Patients taking oral bisphosphonates for the first time may be at higher risk of developing scleritis and uveitis (eye diseases), according to an April 2 study in Canadian Medical Association Journal.

The incidence rate among 10,827 first-time bisphosphonate users was 29/10,000 person-years for uveitis and 63/10,000 person-years for scleritis. In contrast, the incidence rate among 923,320 nonusers was 20/10,000 person-years for uveitis and 36/10,000 for scleritis.

"This is the first study that quantifies the risk of uveitis and scleritis with these drugs. In the past, much attention has been given to other adverse events related to these drugs, mainly linking them to increasing the risk of atypical fractures, atrial fibrillation, and gastrointestinal cancer," the lead author said.

It is possible that the release of inflammatory mediators triggered by the use of bisphosphonates may be the mechanism behind the development of scleritis and uveitis among first-time users. Left untreated, uveitis can lead to cataracts, glaucoma, macular edema, and scleral perforation.


Hair Loss Medication
 
Two Merck & Co. drugs, one to treat hair loss in men (Propecia), the other to treat an enlarged prostate gland (Proscar), will get revised labels warning of potential sexual side effects that can last even after patients stop taking the drugs. Both drugs share the same chemical compound, called finasteride. 

The new Propecia label will include a warning of "libido disorders, ejaculation disorders, and orgasm disorders that continued after discontinuation of the drug," the FDA said in a recent news release.The Proscar label will include a warning about "decreased libido that continued after discontinuation of the drug," the agency said. The labels of both drugs will also carry about a description of reports of male infertility and/or poor semen quality that clears up or improves after the drugs are stopped.

Statins 
Statins were responsible for rhabdomyolysis (muscle breakdown) in 7.5% of patients diagnosed with the skeletal muscle condition, according to a review of International Classification of Disease, Ninth Edition (ICD-9) codes. Publishing their findings as a letter to the editor in the Journal of the American Medical Association, reseacrhers also confirmed a significantly higher risk of rhabdomyolysis in patients treated with high doses of simvastatin.

In a separate warning from the FDA,
taking Statins With HIV or Hepatitis C Drugs raises muscle injury risk

Weight-Loss Medication
Orlistat is an inhibitor of gastric and pancreatic lipase with proven efficacy in the augmentation and maintenance of weight loss. Although its use has been limited by troublesome but benign gastrointestinal side effects, it has more recently been associated with acute kidney injury (AKI). In a Therapeutic Advances in Drug Research review, although the author's cannot yet draw an unequivocal causal link between orlistat and AKI, there is enough evidence to include orlistat exposure in the clinical assessment of patients with AKI.

MedWatch's Most Recent Safety Page
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm300978.htm?source=govdelivery

Friday, April 20, 2012

The future of disease screening

(continued)
Researchers have compiled a detailed molecular profile of an individual, with the goal of learning how to construct an integrative personal "omics" profile, how the profile changes in health and disease, and how to use this information to gauge risk and better understand disease states.

The report, published in Cell, analyzed molecular changes observed in health and disease, including the unexpected development of type 2 diabetes during the study. The group leader Michael Snyder, PhD, chair of the Department of Genetics, Stanford University School of Medicine, provided about 20 blood samples during the 14-month study for analyses, using peripheral blood mononuclear cells, plasma, and sera. Although the 14-month study has now been published, the sampling and analysis continue. "Realistically, other things may happen to me over the rest of my life, and we hope to capture those as well," Initial whole-genome sequencing (WGS) of Dr. Snyder's DNA was performed using several technologies, as was exome sequencing (the part of the genome coding for proteins and other gene products).

Overall, his blood samples were analyzed for nearly 40,000 variables, including profiles of 19,000 or more transcripts that carry the information from about 12,000 genes, levels of 4000 proteins, and 5000 metabolite peaks (only 1000 are known). The results revealed disease variants associated with emphysema, aplastic anemia, type 2 diabetes, and hypertriglyceridemia, among other diseases. The RiskOGram algorithm, which "integrates information from multiple alleles associated with disease risk," indicated an elevated risk for coronary artery disease, basal cell carcinoma, hypertriglyceridemia, and type 2 diabetes.

"Right now we're trying to collect as much information as we can, and we'd like to do this, obviously, with multiple individuals. It may be, at the end of the day, you don't need to make 40,000 measurements like we did on me," said Dr. Snyder. However, "for the average person, I still think it's going to be more than 20 like we do now.... We should be profiling hundreds, if not thousands, kind of routinely as part of an exam." More information is available that way, he said. Asked which analyses were most informative clinically, Dr. Snyder laughed. "I know this will sound like a cop-out, but for me, it was best to analyze everything."

The transcriptome found the most information, but if they had only looked at the transcriptome, they would have missed other equally relevant things, he said. "Some signatures showed up with just the proteomics, and some only showed up with all 3 profiles [transcriptome, proteome, metabolome].... There's really more information in all 3 than in any 1 of these alone," Dr. Snyder added. "We didn't know that for sure going in, but it was refreshing and somewhat reassuring to see this. It makes sense that you'll get a more complete picture when you follow everything."

One goal of the study was to compare molecular analyses in health and disease. Dr. Snyder developed 2 viral infections during the study: a rhinovirus infection on day 0, and a respiratory syncytial virus (RSV) infection starting on day 289. Twelve days later (day 301), his glucose levels became elevated. The elevation lasted several months until, based on glucose levels and HbA1c, his physician diagnosed type 2 diabetes on day 369. "People have associated diabetes with stress responses before, but to the best of my knowledge, not with viral infections. So this was a new angle," Dr. Snyder noted. "It could be that the virus acted like a stress inducer. Our interpretation of this is that my genome has me predisposed and that, in combination with the viral infection, maybe the stress-response part of the viral infection induced the disease." Asked why this infection induced diabetes when previous infections had not, Dr. Snyder said: "This RSV is a pretty nasty one. Another factor may be the case as well: I'm in my 50s and, to be honest, that's when things break down. It's quite likely that the combination of being in my 50s, with this viral stress and, again, my genome combination is what triggered it."

Diabetes should be regarded as "hundreds of diseases," noted Dr. Snyder. "Some people are insulin-resistant, some aren't; some respond to metformin, some don't; some seem to be associated with inflammation, some aren't. So I think diabetes probably is many diseases, all lumped together, because the 1 common characteristic is high glucose. I'm hopeful that by doing more of these sorts of studies, we can look at the molecular breakdown of how many types there are, and then be able to better stratify it and better treat it," Dr. Snyder said.

"I foresee that a longitudinal 'Omics' study as described in Snyder's landmark paper will indeed become common in the next 10 to 20 years," said Jan Korbel, PhD, group leader at the European Molecular Biology Laboratory, Heidelberg, Germany.

"A first promising application would be in families with particular hereditary risk factors, where whole-omics profiling could be used to monitor disease onset closely." George M. Church, PhD, professor of genetics at Harvard Medical School, Boston, Massachusetts, anticipates that work-ups of this type might become common for individuals in "maybe 4 years."

Eric J. Topol, MD, professor of translational genomics at the Scripps Research Institute, La Jolla, California, expects that such work-ups could "be common now for select individuals with a rare, disabling, even life-threatening condition.

Unlike the Snyder study of 20 serial blood draws...a single assessment is eminently doable and could shed considerable light on root cause and potential targeted therapy." "I think it's going to be the future of medicine," concluded Dr. Snyder. "I'd love to see medicine in the future be a case where you get a little prick in your finger, just like a diabetes test, and you measure 5000 things instead of 1 thing (just glucose) right now. I'd love to see it be a home test, where you can monitor your own health routinely," he said. "That's my vision for medicine in the future."

Friday, April 13, 2012

Mood Update

Keeping up with the copious amount of data regarding mood and mood-related disorders can be daunting. We have encapsulated the latest data that we feel can be most helpful to you with regard to treatment, exercise, and diet.

TREATMENTS

Deep Brain Stimulation (DBS)
An Archives of General Psychiatry study provides positive data on the safety and long-term efficacy of DBS in patients with treatment-resistant depression, including those with bipolar disorder. Results show that after two years of long-term stimulation, there was a 92% response rate and 58% remission rate in patients in the study. No patient who achieved remission had a relapse.

Hypnosis
Virtual reality hypnosis to manage depression and anxiety is on the horizon. The innovative approach will use a head-mounted display to immerse patients in a 3-dimensional world of sights and sounds. The technology guides patients through the same steps trained clinicians would use during hypnosis. Some patients may find it difficult to visualize the images necessary for deepening trance states, so researchers presenting at the American Pain Society Annual Scientific Meeting hope the computer-simulated environment will make this easier.

Cognitive Behavioral Therapy (CBT)
Targeting depression in patients with diabetes was associated with improvements in overall health, according to research in Medical Care. With depression being a common, treatable issue for many people who have diabetes, the study was particularly interesting because CBT was delivered by telephone, which can promote greater participation when office visits are not required.

Mindfulness-based cognitive therapy (MBCT) is as effective in preventing relapse in patients with recurrent major depressive disorder (MDD) as maintenance antidepressant monotherapy, according to a study in Archives of General Psychiatry. This makes it an important option for a number of different subpopulations who become depressed, such as pregnant women, who should not be taking antidepressants. Coming off medication can also trigger a relapse. People can come off their medication knowing that there is an option that is nonpharmacological and protects them to the same degree.

Transcranial Magnetic Stimulation (TMS)
Psychiatric researchers have found the non-invasive, non-drug therapy to be an effective, long-term treatment for major depression. Results of the study were published in Brain Stimulation. This is the only prospective, maintenance, follow-up study which assesses the durability of acute TMS benefit in patients with major depression.

Trigeminal Nerve Stimulation (TNS)
This unique new therapy that applies electrical stimulation to a major nerve emanating from the brain is showing promise. In journal Neurology, TNS achieved an average 70 percent reduction in symptom severity over the eight-week study. 80 percent of the subjects achieved remission. Electrodes transmit an electrical current to the nerve. All the patients in the trial used the device for approximately eight hours every night while asleep. In contrast to antidepressants, no major side effects were noted.

EXERCISE

Crucial for reducing depression in aging populations
An American Journal of Preventive Medicine study examined the associations between changes in physical activity and depressive symptoms in a population of older adults over an 11-year period. The researchers found that physical activity engagement in later life was associated with a lower risk of subsequent depressive symptoms. The finding, first of its kind, has underlying implications for future physical activity and mental health promotion in aged populations.

DIET

Nuts are at it again
In the Journal of Proteome Research, scientists report a link between eating nuts and higher levels of serotonin in the bodies of patients with metabolic syndrome, who are at high risk for depression. Serotonin is a substance that helps transmit nerve signals, decreases feelings of hunger, and makes people feel happier. It took only one ounce of mixed nuts (raw unpeeled walnuts, almonds and hazelnuts) a day to produce the good effects.

Water
Even mild dehydration may affect our moods and ability to concentrate, according to a Journal Nutrition study of healthy women with an average age of 23. Mild dehydration dampened moods, increased fatigue, and led to headaches. For most healthy people, six to eight glasses of 8 ounces of water per day is what the researchers suggested drinking.

Omega 3:Omega 6 Balance
Studies have suggested a link between lower omega-3 polyunsaturated fatty acids and higher omega-6 with inflammation and depression. In healthy young adult subjects, researchers in
Brain, Behavior, and Immunity gave either n-3 (2.5 grams per day of EPA and 348 mg of DHA) or placebo capsules. Compared to controls, those students who received n-3 showed a 14% decrease in inflammation and a 20% reduction in anxiety symptoms.

Tuesday, April 3, 2012

Medication and Supplement Alert

Red Yeast Rice: Buyer Beware
Red yeast rice is a commonly used supplement for lowering cholesterol. The fermentation process for producing red yeast rice naturally produces a small concentration of lovastatin and related compounds. Authors in the April issue of
Journal of Evidence-Based Complementary & Alternative Medicine evaluated label information and contacted manufacturers to inquire about lovastatin content in 117 commercially available red yeast rice supplement products. Only 14% of the products evaluated included information about lovastatin content on the label. More than 80% of the products had no information on the label and the manufacturer was not able or willing to provide any information about lovastatin content. Many consumers who choose to take red yeast rice choose to do so in order to avoid conventional prescription medications such as statin drugs. Most of these consumers do not realize that red yeast rice can contain the prescription drug lovastatin. While naturally-occurring and not synthetic like medication, consumers should still be made aware.

FDA Warning About Celexa and Potential Risk of Abnormal Heart Rhythms
FDA is clarifying dosing and warning recommendations for the antidepressant Celexa (citalopram hydrobromide; also available in generic form). In August 2011, FDA issued a Drug Safety Communication (DSC) stating that citalopram should no longer be used at doses greater than 40 mg per day because it could cause potentially dangerous abnormalities in the electrical activity of the heart. Citalopram use at any dose is discouraged in patients with certain conditions because of the risk of QT prolongation, but because it may be important for some of those patients to use citalopram, the drug label has been changed to describe the particular caution that needs to be taken when citalopram is used in such patients. The revised drug label also describes lower doses that should be used in patients over 60 years of age.

RECOMMENDATIONS:Citalopram is not recommended for use at doses greater than 40 mg per day because such doses cause too large an effect on the QT interval and confer no additional benefit.Citalopram is not recommended for use in patients with congenital long QT syndrome, bradycardia, hypokalemia, or hypomagnesemia, recent acute myocardial infarction, or uncompensated heart failure. Citalopram use is also not recommended in patients who are taking other drugs that prolong the QT interval.The maximum recommended dose of citalopram is 20 mg per day for patients with hepatic impairment, patients who are older than 60 years of age, patients who are CYP 2C19 poor metabolizers, or patients who are taking concomitant cimetidine (Tagamet) or another CYP2C19 inhibitor, because these factors lead to increased blood levels of citalopram, increasing the risk of QT interval prolongation and Torsade de Pointes.

Drug-Induced Rheumatic Disease
The purpose of a
Current Opinion in Rheumatology review was that new drugs are continuously being developed and some rheumatic syndromes have been associated with specific drugs. Fifty-three articles comprising 56 case reports are included in the review, with 27 (48.2%) associated with the vasculitides, eight (14.3%) associated with lupus and 13 (23.2%) were associated with the myositis syndromes. The most common four groups of drugs to potentially induce rheumatic diseases were anti-tumor necrosis factor (TNF) drugs, oncology drugs, propylthiouracil and interferons. It is important to recognize that drugs used in other specialties may induce rheumatic disease and vigilance on making a diagnosis is the key.

Statin Medication and Myopathy
Statin-associated myopathy affects up to 10% of patients receiving statin therapy. Although considered a minor adverse effect, it may have a significant effect on patient adherence to statin therapy. While some patients may elect to discontinue therapy after consulting their health care provider, many patients may be able to continue statins with proper management of the adverse effects. Pharmacists should continue to counsel patients on the risk and warning signs of statin-associated myopathy, as the incidence underscores the need for pharmacists to play a direct role in the monitoring of statin therapy in the inpatient and outpatient setting. US Pharmacist, March 2012

Child Poisoning From Medication
Roughly 165 young children in the U.S. are treated in the emergency departments every day after getting into medications, says a new report from Safe Kids Worldwide. That's more than 60,000 kids a year ages 5 and under who unintentionally take a medicine or overdose on it. The number of poisoning deaths linked to accidental medication poisoning has almost doubled from 36% in 1979 to about 64% in 2006.

Based on calls made to poison control centers in 2010, pain relievers — both prescription and over-the-counter — accounted for 31% of fatal poisonings in children age 5 and under. Allergy pills and sedatives, such as sleeping pills or antidepressants, each represent 17% of fatal poisonings in youngsters. Here are ways to avoid accidental poisonings:
  • Store medicine in a safe and secure location that's out of sight and reach of young children (even if another dose needs to be given in a few hours).
  • Don't refer to medicines as candy.
  • Ask guests and babysitters to keep coats, purses, and bags with medicines in them up and away and out of sight when they visit your home.
  • Close child-resistant caps on medicine bottles every time and keep them off counters.
  • Don't use kitchen spoons to measure medicine since they are inaccurate.
  • Adults should avoid taking their medicine in front of children because they like to imitate grownups.
Recent Medication Label Changes by FDA
Monthly Safety Labeling Changes includes 65 products with revisions to Prescribing Information. Posted 03/15/2012
Abilify (aripiprazole) Tablets, Orally Disintegrating Tablets, Oral Solution, and Injection
Amturnide (amlodipine/aliskiren/hydrochlorothiazide) tablets
Angeliq (drospirenone and estradiol) tablets
Aptivus (tipranavir) Capsules and Oral Solution
Avalide (irbesartan/hydrochlorothiazide) tablets
Benicar (olmesartan medoxomil) Tablets
Beyaz (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium) tablets
Cardiogen-82 (Rubidium Rb 82 Generator)
Crestor (rosuvastatin calcium) Tablets
Crixivan (indinavir sulfate) Capsules
Diovan HCT (valsartan/hydrochlorothiazide) Tablets
EES (erythromycin ethylsuccinate) Granules for oral suspension, Eryc (erythromycin delayed-release) capsules, Ery-Ped liquid and
PCE (erythromycin particles in tablets) 333 mg and 500 mg film coated tablets
Elestrin (estradiol gel)
Exforge HCT (amlodipine/valsartan/hydrochlorothiazide) tablets
Famvir (famciclovir) Tablets
Hepsera (adefovir dipivoxil) tablets
Invirase (saquinavir mesylate) Capsules and Tablets
Kaletra (lopinavir/ritonavir) Tablets and Oral Solution
Lescol (fluvastatin sodium) Capsules
Lescol XL (fluvastatin sodium) Extended-Release Tablets
Letairis (ambrisentan) Tablets
Lexiva (fosamprenavir calcium) tablets and oral suspension
Lipitor (atorvastatin calcium) Tablets
Livalo (pitavastatin) tablets
Lotensin HCT (benazepril HCl and hydrochlorothiazide) Tablets
Mevacor (lovastatin) Tablets
Natazia (estradiol valerate and estradiol valerate/dienogest) tablets
Norvir (ritonavir) oral solution and tablets
Orencia (abatacept) for injection
Ozurdex (dexamethasone intravitreal) implant
Patanase (olopatadine hydrochloride) Nasal Spray
Phendimetrazine tartrate SR 105 mg capsules
Pravachol (pravastatin sodium) Tablets
Premarin (conjugated estrogens) Vaginal Cream
Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) and Premphase (conjugated estrogens plus medroxyprogesterone acetate) tablets
Prezista (darunavir), Oral suspension
Reyataz (atazanavir sulfate) Capsules
Rituxan (rituximab) Intravenous Injection
Safyral (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium) tablets
Simcor (niacin ER/simvastatin) Tablets
Tekamlo (aliskiren/amlodipine) tablets
Tekturna (aliskiren) and Tekturna HCT (aliskiren/hydrochlorothiazide) Tablets
Valturna (aliskiren/valsartan) tablets
Vaseretic (enalapril maleate/hydrochlorothiazide) Tablets
Vasotec (enalapril maleate) Tablets
Viracept (nelfinavir mesylate) Oral Powder
Vytorin (ezetimibe/simvastatin) Tablets
Xalkori (crizotinib) Capsules
Yasmin (drospirenone/ethinyl estradiol) tablets
Zocor (simvastatin) Tablets
Zyvox (linezoid) Tablets and Oral Suspension

For label change details, go to http://www.fda.gov/Safety/MedWatch/SafetyInformation
/ucm294217.htm?source=govdelivery